Literature DB >> 22188991

Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries.

Oktay Tutarel1, Seema Dangwal, Julia Bretthauer, Mechthild Westhoff-Bleck, Philipp Roentgen, Stefan D Anker, Johann Bauersachs, Thomas Thum.   

Abstract

BACKGROUND: Recently, the microRNA miR-423_5p was identified as a biomarker for left ventricular heart failure. Its role in patients with a systemic right ventricle and reduced ejection fraction after atrial repair for transposition of the great arteries has not been evaluated.
METHODS: In 41 patients and 10 age- and sex-matched healthy controls circulating miR-423_5p concentration was measured and correlated to clinical parameters, cardiac functional parameters assessed by magnetic resonance imaging, and cardiopulmonary exercise testing.
RESULTS: Levels of circulating miR-423_5p showed no difference between patients and controls. Further, there was no correlation between miR-423_5p and parameters of cardiopulmonary exercise testing or imaging findings.
CONCLUSIONS: In patients with a systemic right ventricle and reduced ejection fraction miR-423_5p levels are not elevated. Therefore, circulating miR-423_5p is not a useful biomarker for heart failure in this patient group.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22188991     DOI: 10.1016/j.ijcard.2011.11.082

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

Review 1.  Clinical use of novel biomarkers in heart failure: towards personalized medicine.

Authors:  Daniela Schmitter; Gadi Cotter; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 2.  The biology of circulating microRNAs in cardiovascular disease.

Authors:  Pil-Ki Min; Stephen Y Chan
Journal:  Eur J Clin Invest       Date:  2015-08       Impact factor: 4.686

3.  Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy.

Authors:  Kuan-Lu Fan; Hai-Feng Zhang; Jie Shen; Qi Zhang; Xin-Li Li
Journal:  Indian Heart J       Date:  2012-12-28

Review 4.  MicroRNAs as biomarkers for ischemic heart disease.

Authors:  Lucas N L Van Aelst; Stephane Heymans
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

5.  Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers.

Authors:  Kemal Marc Akat; D'Vesharronne Moore-McGriff; Pavel Morozov; Miguel Brown; Tasos Gogakos; Joel Correa Da Rosa; Aleksandra Mihailovic; Markus Sauer; Ruiping Ji; Aarthi Ramarathnam; Hana Totary-Jain; Zev Williams; Thomas Tuschl; P Christian Schulze
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-10       Impact factor: 11.205

Review 6.  MicroRNAs in heart failure: Non-coding regulators of metabolic function.

Authors:  Xiaokan Zhang; P Christian Schulze
Journal:  Biochim Biophys Acta       Date:  2016-08-18

Review 7.  MicroRNAs in right ventricular (dys)function (2013 Grover Conference series).

Authors:  Thomas Thum; Sandor Batkai
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 8.  Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.

Authors:  Golnoosh Mahjoob; Yasin Ahmadi; Huda Fatima Rajani; Nafiseh Khanbabaei; Sakhavat Abolhasani
Journal:  J Clin Lab Anal       Date:  2022-03-29       Impact factor: 3.124

Review 9.  Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication.

Authors:  Virginie Kinet; Julie Halkein; Ellen Dirkx; Leon J De Windt
Journal:  Front Genet       Date:  2013-11-12       Impact factor: 4.599

10.  Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries.

Authors:  Clare T M Lai; Enders K O Ng; Pak-cheong Chow; Ava Kwong; Yiu-fai Cheung
Journal:  BMC Cardiovasc Disord       Date:  2013-09-16       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.